- Olink announced in December 2018 that oncology's 92-plex protein biomarker panel is now accessible as kits or as an analysis service. In two specialized panels, this novel biomarker panel can test 184 proteins. This novel assays panel covers a wide range of oncology-related diseases and biological processes.
- PerkinElmer, Inc. announced in October 2014 that they would be exhibiting Omics Office software in London; it is new and revolutionary software for qPCR and digital PCR Congress. This new programme assists scientists in importing, analysing, and validating complex data in order to make informed conclusions. This software can help you visualise and analyse biological data at a high level of sophistication. The company's product portfolio has been expanded in the market as a result of the debut of this product.
Frequently Asked Questions
The market is segmented based on Asia-Pacific Polymerase Chain Reaction (PCR) Multiplex Assays Market Segmentation, By Products and Services (Reagents and Consumables, Instruments and Accessories, Software and Services), Applications (Clinical Diagnostics, Research and Development), End-User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutes, Others) – Industry Trends and Forecast to 2032
.
The Asia Pacific Pcr Multiplex Assays Market size was valued at USD 1.21 USD Million in 2024.
The Asia Pacific Pcr Multiplex Assays Market is projected to grow at a CAGR of 9.1% during the forecast period of 2025 to 2032.
The market report covers data from the Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel.
